|
C15ORF23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.758100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.939600E-03 |
| Normal-vs-Stage2 |
1.081650E-02 |
| Normal-vs-Stage3 |
1.561130E-03 |
| Normal-vs-Stage4 |
4.263200E-03 |
| Stage1-vs-Stage2 |
8.390400E-01 |
| Stage1-vs-Stage3 |
3.765200E-01 |
| Stage1-vs-Stage4 |
8.707200E-01 |
| Stage2-vs-Stage3 |
4.073600E-01 |
| Stage2-vs-Stage4 |
7.465200E-01 |
| Stage3-vs-Stage4 |
5.503000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.984220E-03 |
| Normal-vs-AfricanAmerican |
2.882300E-02 |
| Normal-vs-Asian |
5.155400E-04 |
| Caucasian-vs-AfricanAmerican |
4.565000E-01 |
| Caucasian-vs-Asian |
1.945780E-01 |
| AfricanAmerican-vs-Asian |
1.308210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.343800E-03 |
| Normal-vs-Female |
3.298100E-03 |
| Male-vs-Female |
7.207400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.362000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.842100E-03 |
| Normal-vs-Age(61-80Yrs) |
2.177600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.633100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.404200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.239000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.079600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.977000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.376200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.579900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.994000E-01 |
| Classical-VS-Follicular |
3.581300E-04 |
| Classical-VS-Other |
5.902000E-01 |
| Classical-VS-Normal |
9.564400E-04 |
| Tall-VS-Follicular |
2.609500E-04 |
| Tall-VS-Other |
8.464800E-01 |
| Tall-VS-Normal |
6.380900E-04 |
| Follicular-VS-Other |
3.779200E-03 |
| Follicular-VS-Normal |
1.903160E-01 |
| Other-VS-Normal |
1.215240E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.180200E-03 |
| Normal-vs-N1 |
7.646500E-02 |
| N0-vs-N1 |
7.835000E-01 |
|
|
